Johnson & Johnson (JNJ) Tops Q2 EPS by 5c; Reaffirms Guidance
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $267.28 --0%
EPS Growth %: +3.6%
Financial Fact:
Research and development expense: 2.18B
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +3.6%
Financial Fact:
Research and development expense: 2.18B
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $1.28, $0.05 better than the analyst estimate of $1.23. Revenue for the quarter came in at $16.6 billion versus the consensus estimate of $16.22 billion.
Reaffirms outlook.
Reaffirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Fluence Energy cuts fiscal 2026 revenue outlook on supply chain woes
- J&J lung cancer drug combo shows low side effect rates in study
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
